2014-2026 Global Exocrine Pancreatic Insufficiency Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
SKU ID :Maia-14763521 | Published Date: 10-Dec-2019 | No. of pages: 131Description
TOC
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2014-2026)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Exocrine Pancreatic Insufficiency Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Exocrine Pancreatic Insufficiency Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Exocrine Pancreatic Insufficiency Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Exocrine Pancreatic Insufficiency Market-Segmentation by Type
5.1 Pancreatic Enzyme Replacement Therapy (Creon, Zenpep, Pancreaze, Ultresa, Viokase, Pertzye)
5.2 Phase III Drugs
6 Global Exocrine Pancreatic Insufficiency Market-Segmentation by Application
6.1 Hospital Pharmacy
6.2 Retail Pharmacy
6.3 Online Sales
6.4 Others
7 Global Exocrine Pancreatic Insufficiency Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence – Company Profiles
8.1 Janssen Pharmaceuticals Inc.
8.1.1 Janssen Pharmaceuticals Inc. Profile
8.1.2 Janssen Pharmaceuticals Inc. Sales, Growth Rate and Global Market Share from 2014-2019E
8.1.3 Janssen Pharmaceuticals Inc. Product/Solution Launches and Enhancements Analysis
8.1.4 Janssen Pharmaceuticals Inc. Business Overview/Recent Development/Acquisitions
8.2 Anthera Pharmaceuticals Inc.
8.2.1 Anthera Pharmaceuticals Inc. Profile
8.2.2 Anthera Pharmaceuticals Inc. Sales, Growth Rate and Global Market Share from 2014-2019E
8.2.3 Anthera Pharmaceuticals Inc. Product/Solution Launches and Enhancements Analysis
8.2.4 Anthera Pharmaceuticals Inc. Business Overview/Recent Development/Acquisitions
8.3 Abbvie Inc.
8.3.1 Abbvie Inc. Profile
8.3.2 Abbvie Inc. Sales, Growth Rate and Global Market Share from 2014-2019E
8.3.3 Abbvie Inc. Product/Solution Launches and Enhancements Analysis
8.3.4 Abbvie Inc. Business Overview/Recent Development/Acquisitions
8.4 Cilian AG
8.4.1 Cilian AG Profile
8.4.2 Cilian AG Sales, Growth Rate and Global Market Share from 2014-2019E
8.4.3 Cilian AG Product/Solution Launches and Enhancements Analysis
8.4.4 Cilian AG Business Overview/Recent Development/Acquisitions
8.5 Digestive Care, Inc.
8.5.1 Digestive Care, Inc. Profile
8.5.2 Digestive Care, Inc. Sales, Growth Rate and Global Market Share from 2014-2019E
8.5.3 Digestive Care, Inc. Product/Solution Launches and Enhancements Analysis
8.5.4 Digestive Care, Inc. Business Overview/Recent Development/Acquisitions
8.6 Nordmark Arzneimittel GmbH & Co. KG
8.6.1 Nordmark Arzneimittel GmbH & Co. KG Profile
8.6.2 Nordmark Arzneimittel GmbH & Co. KG Sales, Growth Rate and Global Market Share from 2014-2019E
8.6.3 Nordmark Arzneimittel GmbH & Co. KG Product/Solution Launches and Enhancements Analysis
8.6.4 Nordmark Arzneimittel GmbH & Co. KG Business Overview/Recent Development/Acquisitions
8.7 AzurRx BioPharma, Inc.
8.7.1 AzurRx BioPharma, Inc. Profile
8.7.2 AzurRx BioPharma, Inc. Sales, Growth Rate and Global Market Share from 2014-2019E
8.7.3 AzurRx BioPharma, Inc. Product/Solution Launches and Enhancements Analysis
8.7.4 AzurRx BioPharma, Inc. Business Overview/Recent Development/Acquisitions
8.8 Allergan plc.
8.8.1 Allergan plc. Profile
8.8.2 Allergan plc. Sales, Growth Rate and Global Market Share from 2014-2019E
8.8.3 Allergan plc. Product/Solution Launches and Enhancements Analysis
8.8.4 Allergan plc. Business Overview/Recent Development/Acquisitions
9 Global Exocrine Pancreatic Insufficiency Market-Segmentation by Geography
10 North America
10.1 North America Exocrine Pancreatic Insufficiency Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
10.2 North America Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
10.3 North America Exocrine Pancreatic Insufficiency Production Analysis from 2014-2019E
10.4 North America Exocrine Pancreatic Insufficiency Consumption Analysis from 2014-2019E
10.5 North America Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E
10.6 North America Exocrine Pancreatic Insufficiency Value, Production and Market Share by Type (2014-2019E)
10.7 North America Exocrine Pancreatic Insufficiency Consumption, Value and Market Share by Application (2014-2019E)
10.8 North America Exocrine Pancreatic Insufficiency by Country (United States, Canada)
10.8.1 North America Exocrine Pancreatic Insufficiency Sales by Country (2014-2019E)
10.8.2 North America Exocrine Pancreatic Insufficiency Consumption Value by Country (2014-2019E)
10.9 North America Exocrine Pancreatic Insufficiency Market PEST Analysis
11 Europe
11.1 Europe Exocrine Pancreatic Insufficiency Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
11.2 Europe Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
11.3 Europe Exocrine Pancreatic Insufficiency Production Analysis from 2014-2019E
11.4 Europe Exocrine Pancreatic Insufficiency Consumption Analysis from 2014-2019E
11.5 Europe Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E
11.6 Europe Exocrine Pancreatic Insufficiency Value, Production and Market Share by Type (2014-2019E)
11.7 Europe Exocrine Pancreatic Insufficiency Consumption, Value and Market Share by Application (2014-2019E)
11.8 Europe Exocrine Pancreatic Insufficiency by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Exocrine Pancreatic Insufficiency Sales by Country (2014-2019E)
11.8.2 Europe Exocrine Pancreatic Insufficiency Consumption Value by Country (2014-2019E)
11.9 Europe Exocrine Pancreatic Insufficiency Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Exocrine Pancreatic Insufficiency Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
12.2 Asia-Pacific Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
12.3 Asia-Pacific Exocrine Pancreatic Insufficiency Production Analysis from 2014-2019E
12.4 Asia-Pacific Exocrine Pancreatic Insufficiency Consumption Analysis from 2014-2019E
12.5 Asia-Pacific Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E
12.6 Asia-Pacific Exocrine Pancreatic Insufficiency Value, Production and Market Share by Type (2014-2019E)
12.7 Asia-Pacific Exocrine Pancreatic Insufficiency Consumption, Value and Market Share by Application (2014-2019E)
12.8 Asia-Pacific Exocrine Pancreatic Insufficiency by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Exocrine Pancreatic Insufficiency Sales by Country (2014-2019E)
12.8.2 Asia-Pacific Exocrine Pancreatic Insufficiency Consumption Value by Country (2014-2019E)
12.9 Asia-Pacific Exocrine Pancreatic Insufficiency Market PEST Analysis
13 Latin America
13.1 Latin America Exocrine Pancreatic Insufficiency Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
13.2 Latin America Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
13.3 Latin America Exocrine Pancreatic Insufficiency Production Analysis from 2014-2019E
13.4 Latin America Exocrine Pancreatic Insufficiency Consumption Analysis from 2014-2019E
13.5 Latin America Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E
13.6 Latin America Exocrine Pancreatic Insufficiency Value, Production and Market Share by Type (2014-2019E)
13.7 Latin America Exocrine Pancreatic Insufficiency Consumption, Value and Market Share by Application (2014-2019E)
13.8 Latin America Exocrine Pancreatic Insufficiency by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Exocrine Pancreatic Insufficiency Sales by Country (2014-2019E)
13.8.2 Latin America Exocrine Pancreatic Insufficiency Consumption Value by Country (2014-2019E)
13.9 Latin America Exocrine Pancreatic Insufficiency Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Exocrine Pancreatic Insufficiency Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E
14.2 Middle East & Africa Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E
14.3 Middle East & Africa Exocrine Pancreatic Insufficiency Production Analysis from 2014-2019E
14.4 Middle East & Africa Exocrine Pancreatic Insufficiency Consumption Analysis from 2014-2019E
14.5 Middle East & Africa Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E
14.6 Middle East & Africa Exocrine Pancreatic Insufficiency Value, Production and Market Share by Type (2014-2019E)
14.7 Middle East & Africa Exocrine Pancreatic Insufficiency Consumption, Value and Market Share by Application (2014-2019E)
14.8 Middle East & Africa Exocrine Pancreatic Insufficiency by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Exocrine Pancreatic Insufficiency Sales by Country (2014-2019E)
14.8.2 Middle East & Africa Exocrine Pancreatic Insufficiency Consumption Value by Country (2014-2019E)
14.9 Middle East & Africa Exocrine Pancreatic Insufficiency Market PEST Analysis
15 Future Forecast of the Global Exocrine Pancreatic Insufficiency Market from 2018-2026
15.1 Future Forecast of the Global Exocrine Pancreatic Insufficiency Market from 2019-2026 Segment by Region
15.2 Global Exocrine Pancreatic Insufficiency Production and Growth Rate Forecast by Type (2019-2026)
15.3 Global Exocrine Pancreatic Insufficiency Consumption and Growth Rate Forecast by Application (2019-2026)
16 Appendix
16.1 Methodology
16.2 Research Data Source
Tables & Figures
List of Tables and Figures
Global Exocrine Pancreatic Insufficiency Market Value ($) and Growth Rate of Exocrine Pancreatic Insufficiency from 2014-2026
Global Exocrine Pancreatic Insufficiency Production and Growth Rate Segment by Product Type from 2014-2026F
Global Exocrine Pancreatic Insufficiency Consumption and Growth Rate Segment by Application from 2014-2019E
Figure Exocrine Pancreatic Insufficiency Picture
Table Product Specifications of Exocrine Pancreatic Insufficiency
Table Driving Factors for this Market
Table Industry News of Exocrine Pancreatic Insufficiency Market
Figure Value Chain Status of Exocrine Pancreatic Insufficiency
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Exocrine Pancreatic Insufficiency Production and Growth Rate Segment by Product Type from 2014-2019E
Table Global Exocrine Pancreatic Insufficiency Value ($) and Growth Rate Segment by Product Type from 2014-2019E
Figure Pancreatic Enzyme Replacement Therapy (Creon, Zenpep, Pancreaze, Ultresa, Viokase, Pertzye) of Exocrine Pancreatic Insufficiency
Figure Phase III Drugs of Exocrine Pancreatic Insufficiency
Table Global Exocrine Pancreatic Insufficiency Consumption and Growth Rate Segment by Application from 2014-2019E
Table Global Exocrine Pancreatic Insufficiency Value ($) and Growth Rate Segment by Application from 2014-2019E
Figure Hospital Pharmacy of Exocrine Pancreatic Insufficiency
Figure Retail Pharmacy of Exocrine Pancreatic Insufficiency
Figure Online Sales of Exocrine Pancreatic Insufficiency
Figure Others of Exocrine Pancreatic Insufficiency
Table Global Exocrine Pancreatic Insufficiency Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E
Table Global Exocrine Pancreatic Insufficiency Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E
Figure Traditional Marketing Channel (Offline) of Exocrine Pancreatic Insufficiency
Figure Online Channel of Exocrine Pancreatic Insufficiency
Table Janssen Pharmaceuticals Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Janssen Pharmaceuticals Inc. Sales and Growth Rate from 2014-2019E
Figure Janssen Pharmaceuticals Inc. Revenue ($) and Global Market Share from 2014-2019E
Table Janssen Pharmaceuticals Inc. Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Anthera Pharmaceuticals Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Anthera Pharmaceuticals Inc. Sales and Growth Rate from 2014-2019E
Figure Anthera Pharmaceuticals Inc. Revenue ($) and Global Market Share from 2014-2019E
Table Anthera Pharmaceuticals Inc. Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Abbvie Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Abbvie Inc. Sales and Growth Rate from 2014-2019E
Figure Abbvie Inc. Revenue ($) and Global Market Share from 2014-2019E
Table Abbvie Inc. Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Cilian AG Profile (Company Name, Plants Distribution, Sales Region)
Figure Cilian AG Sales and Growth Rate from 2014-2019E
Figure Cilian AG Revenue ($) and Global Market Share from 2014-2019E
Table Cilian AG Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Digestive Care, Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Digestive Care, Inc. Sales and Growth Rate from 2014-2019E
Figure Digestive Care, Inc. Revenue ($) and Global Market Share from 2014-2019E
Table Digestive Care, Inc. Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Nordmark Arzneimittel GmbH & Co. KG Profile (Company Name, Plants Distribution, Sales Region)
Figure Nordmark Arzneimittel GmbH & Co. KG Sales and Growth Rate from 2014-2019E
Figure Nordmark Arzneimittel GmbH & Co. KG Revenue ($) and Global Market Share from 2014-2019E
Table Nordmark Arzneimittel GmbH & Co. KG Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E)
Table AzurRx BioPharma, Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure AzurRx BioPharma, Inc. Sales and Growth Rate from 2014-2019E
Figure AzurRx BioPharma, Inc. Revenue ($) and Global Market Share from 2014-2019E
Table AzurRx BioPharma, Inc. Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Allergan plc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Allergan plc. Sales and Growth Rate from 2014-2019E
Figure Allergan plc. Revenue ($) and Global Market Share from 2014-2019E
Table Allergan plc. Exocrine Pancreatic Insufficiency Sales, Price, Revenue, Gross Margin (2014-2019E)
Table Global Exocrine Pancreatic Insufficiency Production Value ($) by Region from 2014-2019E
Table Global Exocrine Pancreatic Insufficiency Production Value Share by Region from 2014-2019E
Table Global Exocrine Pancreatic Insufficiency Production by Region from 2014-2019E
Table Global Exocrine Pancreatic Insufficiency Consumption Value ($) by Region from 2014-2019E
Table Global Exocrine Pancreatic Insufficiency Consumption by Region from 2014-2019E
Table North America Exocrine Pancreatic Insufficiency Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table North America Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table North America Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E
Table North America Exocrine Pancreatic Insufficiency Value ($) by Type (2014-2019E)
Table North America Exocrine Pancreatic Insufficiency Production by Type (2014-2019E)
Table North America Exocrine Pancreatic Insufficiency Consumption by Application (2014-2019E)
Table North America Exocrine Pancreatic Insufficiency Consumption by Country (2014-2019E)
Table North America Exocrine Pancreatic Insufficiency Consumption Value ($) by Country (2014-2019E)
Figure North America Exocrine Pancreatic Insufficiency Market PEST Analysis
Table Europe Exocrine Pancreatic Insufficiency Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table Europe Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table Europe Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E
Table Europe Exocrine Pancreatic Insufficiency Value ($) by Type (2014-2019E)
Table Europe Exocrine Pancreatic Insufficiency Production by Type (2014-2019E)
Table Europe Exocrine Pancreatic Insufficiency Consumption by Application (2014-2019E)
Table Europe Exocrine Pancreatic Insufficiency Consumption by Country (2014-2019E)
Table Europe Exocrine Pancreatic Insufficiency Consumption Value ($) by Country (2014-2019E)
Figure Europe Exocrine Pancreatic Insufficiency Market PEST Analysis
Table Asia-Pacific Exocrine Pancreatic Insufficiency Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table Asia-Pacific Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table Asia-Pacific Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E
Table Asia-Pacific Exocrine Pancreatic Insufficiency Value ($) by Type (2014-2019E)
Table Asia-Pacific Exocrine Pancreatic Insufficiency Production by Type (2014-2019E)
Table Asia-Pacific Exocrine Pancreatic Insufficiency Consumption by Application (2014-2019E)
Table Asia-Pacific Exocrine Pancreatic Insufficiency Consumption by Country (2014-2019E)
Table Asia-Pacific Exocrine Pancreatic Insufficiency Consumption Value ($) by Country (2014-2019E)
Figure Asia-Pacific Exocrine Pancreatic Insufficiency Market PEST Analysis
Table Latin America Exocrine Pancreatic Insufficiency Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table Latin America Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table Latin America Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E
Table Latin America Exocrine Pancreatic Insufficiency Value ($) by Type (2014-2019E)
Table Latin America Exocrine Pancreatic Insufficiency Production by Type (2014-2019E)
Table Latin America Exocrine Pancreatic Insufficiency Consumption by Application (2014-2019E)
Table Latin America Exocrine Pancreatic Insufficiency Consumption by Country (2014-2019E)
Table Latin America Exocrine Pancreatic Insufficiency Consumption Value ($) by Country (2014-2019E)
Figure Latin America Exocrine Pancreatic Insufficiency Market PEST Analysis
Table Middle East & Africa Exocrine Pancreatic Insufficiency Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E
Table Middle East & Africa Exocrine Pancreatic Insufficiency Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E
Table Middle East & Africa Exocrine Pancreatic Insufficiency Import and Export from 2014-2019E
Table Middle East & Africa Exocrine Pancreatic Insufficiency Value ($) by Type (2014-2019E)
Table Middle East & Africa Exocrine Pancreatic Insufficiency Production by Type (2014-2019E)
Table Middle East & Africa Exocrine Pancreatic Insufficiency Consumption by Application (2014-2019E)
Table Middle East & Africa Exocrine Pancreatic Insufficiency Consumption by Country (2014-2019E)
Table Middle East & Africa Exocrine Pancreatic Insufficiency Consumption Value ($) by Country (2014-2019E)
Figure Middle East & Africa Exocrine Pancreatic Insufficiency Market PEST Analysis
Table Global Exocrine Pancreatic Insufficiency Value ($) and Growth Rate Forecast by Region (2018-2026)
Table Global Exocrine Pancreatic Insufficiency Production and Growth Rate Forecast by Region (2019-2026)
Table Global Exocrine Pancreatic Insufficiency Consumption and Growth Rate Forecast by Region (2019-2026)
Table Global Exocrine Pancreatic Insufficiency Production and Growth Rate Forecast by Type (2019-2026)
Table Global Exocrine Pancreatic Insufficiency Consumption and Growth Rate Forecast by Application (2019-2026)
Companies
- PRICE
-
$3460$5000